Company news

Cardiol Therapeutics Inc. news in 2019

Cardiol Therapeutics Inc.'s news releases, calls and decks from 2019, newest first.

View company

Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

December 18, 2019

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors

December 3, 2019

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

November 25, 2019

Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

November 19, 2019

Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx(TM)100

October 1, 2019

Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

September 16, 2019

Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th

September 5, 2019

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th

September 5, 2019

Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

July 25, 2019

Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing

July 3, 2019

Grit Capital's Live-Stream Virtual Investor Conference June 26th

June 21, 2019

Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation

June 20, 2019

Cardiol Therapeutics Reports Results of its AGM

June 13, 2019

Cardiol Therapeutics to Webcast Annual General Meeting on June 12

June 10, 2019

Cardiol Therapeutics' Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD

June 3, 2019

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

May 31, 2019

Cardiol Therapeutics Commences Trading on the OTCQX

May 30, 2019

Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A

March 28, 2019

Cardiol Therapeutics Appoints Thomas Moffatt as Chief Commercial Officer

March 6, 2019

Cardiol Therapeutics Inc. Closes the Market

January 24, 2019

Cardiol Therapeutics Inc. Closes Over-Allotment

January 18, 2019